for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Gene One Life Science Inc

011000.KS

Latest Trade

14,100.00KRW

Change

-200.00(-1.40%)

Volume

1,211,241

Today's Range

13,800.00

 - 

15,150.00

52 Week Range

3,153.00

 - 

47,550.00

As of on the Korea Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
14,300.00
Open
13,800.00
Volume
1,211,241
3M AVG Volume
41.57
Today's High
15,150.00
Today's Low
13,800.00
52 Week High
47,550.00
52 Week Low
3,153.00
Shares Out (MIL)
44.60
Market Cap (MIL)
631,271.20
Forward P/E
--
Dividend (Yield %)
--

Next Event

Gene One Life Science Inc Annual Shareholders Meeting

Latest Developments

More

Gene One Life Science signs contract worth 2.14 bln won

Gene One Life Science signs contract worth 4.23 bln won

Gene One Life Science to issue 3rd series convertible bonds worth 12 bln won

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Gene One Life Science Inc

GeneOneLifeScience, formerly VGX International, Inc., is a Korea-based company engaged in textile and biopharmaceutical businesses. The Company is a biomedical contract manufacturing organization (CMO). Its textile business engages in the provision of wicks under the brand name of INTERON, which are used in dress shirts, suits and caps. Its biopharmaceutical business engages in the research, development and manufacture of biomedical, plasmid deoxyribonucleic acid (DNA) and DNA vaccines. It also engaged in the leasing of nonresidential buildings.

Industry

Biotechnology & Drugs

Contact Info

Keungil Tower Bldg.

223, Teheran-ro, Gangnam-gu

06060

South Korea

+82.2.60043450

http://www.vgxi.com

Executive Leadership

Yeong Geun Park

Chief Executive Officer, Director

Byeong Mun Cho

Managing Director

Seong Ho Choi

Internal Auditor

Jeon Oh Lee

Non-Executive Independent Director

Sang Gi Oh

Non-Executive Independent Director

Key Stats

Price To Earnings (TTM)
--
Price To Sales (TTM)
15.05
Price To Book (MRQ)
5.74
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
2.38
LT Debt To Equity (MRQ)
2.00
Return on Investment (TTM)
-16.33
Return on Equity (TTM)
-13.45

Latest News

Latest News

BRIEF-Inovio And Geneone Life Science Report Positive Phase 1/2A Clinical Data With Dna Vaccine Ino-4700 For Mers Coronavirus

* INOVIO AND GENEONE LIFE SCIENCE REPORT POSITIVE PHASE 1/2A CLINICAL DATA WITH DNA VACCINE INO-4700 FOR MERS CORONAVIRUS AT THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) CONFERENCE

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up